Clinical trial
Study to Investigate the Efficacy of a Non-hormonal Drug Against Endometriosis…
NCT00185341 · Bayer, Industry · Completed
Key facts
| NCT number | NCT00185341 |
|---|---|
| Title | Study to Investigate the Efficacy of a Non-hormonal Drug Against Endometriosis Associated Pelvic Pain |
| Official title | A Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Evaluate the Safety, Tolerability and Efficacy of the CCR1 Antagonist ZK 811752, Given Orally in a Dose of 600 mg Three Times Daily, for the Treatment of Endometriosis Over 12 Weeks |
| Lead sponsor | Bayer, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Endometriosis |
| Intervention type | Drug |
| Interventions | CCR1-Antagonist (BAY86-5047, ZK811752), Placebo |
| Enrollment | 110 |
| Start date | Feb 1, 2005 |
| Primary completion | Feb 1, 2007 |
| Completion | Feb 1, 2007 |
| First posted | Sep 16, 2005 |
| Last update posted | May 2, 2016 |
| Countries | Czechia, Denmark, Finland, France, Netherlands, Spain, Sweden |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: